Interventional Oncology Devices Global Market By Product Type, By Procedure, By Cancer Type, Opportunity Analysis and Forecast, 2024-2033
The Interventional Oncology
Devices by The Business Research Company provides market overview across 60+
geographies in the seven regions - Asia-Pacific, Western Europe, Eastern
Europe, North America, South America, the Middle East, and Africa, encompassing
27 major global industries. The report presents a comprehensive analysis over a
ten-year historic period (2010-2021) and extends its insights into a ten-year
forecast period (2023-2033).
Learn More On The Interventional Oncology Devices Market:
https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report
According to The Business Research Company’s Interventional Oncology Devices, the
interventional oncology devices market size has grown strongly in recent years.
It will grow from $2.35 billion in 2023 to $2.5 billion in 2024 at a compound
annual growth rate (CAGR) of 6.4%. The growth in the historic period can be
attributed to aging population pool, an increase in cancer prevalence, increase
in pharmaceutical r&d expenditure, increased healthcare expenditure and
growth in the number of healthcare facilities.
The interventional oncology devices market size is expected to see strong
growth in the next few years. It will grow to $3.25 billion in 2028 at a
compound annual growth rate (CAGR) of 6.7%.
The growth in the forecast period can be attributed to increasing older
population, increasing preference towards minimally invasive surgeries (mis),
increasing research and development spending, a rise in healthcare expenditure,
high potential in emerging economies and increasing prevalence of cancer and
chronic diseases. Major trends in the forecast period include focusing on
developing advanced image-guided oncology devices, utilizing ai to develop
innovative devices, developing new, innovative embolic devices to enable
improved oncology procedures, focusing on using robotics technology and
collaborating with other companies and research institutes to accelerate
product development and innovation.
The availability of private and government funding drove the interventional
oncology devices market. In the field of cancer, funding from the government
and private has increased, especially for the devices used in treatments as it
promotes early detection and better survival rates. The American Cancer
Society, the largest non-government, not-for-profit cancer research funder, has
awarded 630 projects with a grant amount of $384,262,652 in 2021. BioProtect
Ltd., an Israeli company that develops novel bioabsorbable polymer spacer
balloons, received a funding of $13 million of its Series D equity financing
from a leading global syndicate of venture investors that finances the ongoing
multicenter FDA clinical trial of BioProtect's lead product, the ProSpace
balloon spacer, which protects prostate cancer patients undergoing radiation
therapy. Endosight, the first augmented-reality-guided ablative system, has
received 20% of its funding from private organizations. The funding from
government and private organizations helps in the development of new
technologies and devices, thereby driving the interventional oncology devices
market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=3304&type=smp
The interventional oncology devices market covered in this report is
segmented –
1) By Product: Embolization Devices, Ablation Devices, Support Devices
2) By procedure: Thermal Tumor Ablation, Non-Thermal Tumor Ablation,
Transcatheter Arterial Chemoembolization (TACE), Transcatheter Arterial
Radioembolization (TARE), Selective Internal Radiation Therapy (SIRT),
Transcatheter Arterial Embolization (TAE), Bland Embolization
3) By Cancer Type: Liver Cancer, Kidney Cancer, Lung Cancer, Bone Cancer, Other
Cancer Types
Major companies are focusing on deploying robotics technology in interventional
oncology devices, for higher efficiency. The robotic system integrates
image-based planning and navigation with the installation of different
instruments to the desired body part with better accuracy and efficiency. For instance,
in March 2022, the U.S. Food and Drug Administration approved Quantum
Surgical’s Epione interventional oncology robotics platform.
The interventional oncology devices market report table of contents
includes:
1. Executive Summary
2. Interventional Oncology Devices Market Characteristics
3. Interventional Oncology Devices Market Trends And Strategies
4. Interventional Oncology Devices Market - Macro Economic
Scenario
5. Global Interventional Oncology Devices Market Size and Growth
.....
32. Global Interventional Oncology Devices Market Competitive
Benchmarking
33. Global Interventional Oncology Devices Market Competitive
Dashboard
34. Key Mergers And Acquisitions In The Interventional Oncology
Devices Market
35. Interventional Oncology Devices Market Future Outlook and
Potential Analysis
36. Appendix
Related Reports
https://topprnews.com/print-label-market
https://topprnews.com/primary-school-market-size
https://topprnews.com/pressure-transducer-market
https://goodprnews.com/print-label-market
https://goodprnews.com/primary-school-market-size
https://goodprnews.com/pressure-transducer-market
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Comments
Post a Comment